15 Costly Drugs Will Get Medicare Price Cuts in 2027: Will You Save?
The Centers for Medicare & Medicaid Services extended a safety net to older Americans by announcing significant price reductions on 15 high-cost prescription drugs, effective in 2027.
On November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) announced significant price reductions for 15 high-cost prescription drugs used by millions of Medicare beneficiaries. That's a major win for older Americans.
The negotiated "maximum fair prices," made possible by the 2022 Inflation Reduction Act, promise to save the program $12 billion annually compared with last year's Medicare spending on 15 widely used drugs to treat cancer and other serious chronic conditions that hit older adults hardest.
Previously, the Biden administration reached deals to lower the costs of 10 prescription drugs, including several for heart disease and diabetes, which are set to take effect in 2026. This latest round of price negotiations will go into effect in 2027, with seniors expected to see an estimated $685 million in out-of-pocket relief.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Historically, prescription drug costs have wreaked havoc on many seniors' budgets, with some rationing doses or skipping their meds altogether due to high costs, according to a survey by research group KFF.
For the roughly 5.3 million Medicare beneficiaries who take these 15 medications, and the new $2,100 annual out-of-pocket cap in Medicare Part D, starting in 2026, 2027 can’t come soon enough.
For decades, Medicare was prohibited by law from negotiating drug prices directly with manufacturers, resulting in older Americans paying two to four times what patients in Europe or Canada paid for the same medicines.
Seniors like 72-year-old retiree Ryan Whitworth of Florida, who relies on Xtandl for prostate cancer, could see his monthly copays halved. “Finally, I won’t have to choose between meds and groceries,” he told Kiplinger.
Below is the full list of the 15 drugs and their new Medicare maximum fair prices compared with the 2024 list prices. All figures are for a typical 30-day supply. The numbers are rounded to the nearest dollar where applicable.
Drug Name | Commonly Treated Conditions | 2024 List Price | 2027 Medicare Price | % Reduction |
Ozempic; Rybelsus; Wegovy | Type 2 diabetes; Type 2 diabetes & cardiovascular disease; Cardiovascular disease & obesity/overweight | $959 | $274 | -71% |
Trelegy Ellipta | Asthma; Chronic obstructive pulmonary disease | $654 | $175 | -73% |
Xtandi | Prostate cancer | $13,480 | $7,004 | -48% |
Pomalyst | Kaposi sarcoma; Multiple myeloma | $21,744 | $8,650 | -60% |
Ofev | Idiopathic pulmonary fibrosis | $12,622 | $6,350 | -50% |
Ibrance | Breast cancer | $15,741 | $7,871 | -50% |
Linzess | Chronic idiopathic constipation; irritable bowel syndrome with constipation | $539 | $136 | -75% |
Calquence | Chronic lymphocytic leukemia/small lymphocytic lymphoma; Mantle cell lymphoma | $14,228 | $8,600 | -40% |
Austedo; Austedo XR | Chorea in Huntington’s disease; Tardive dyskinesia | $6,623 | $4,093 | -38% |
Breo Ellipta | Asthma; Chronic obstructive pulmonary disease | $397 | $67 | -83% |
Xifaxan | Hepatic encephalopathy; Irritable bowel syndrome with diarrhea | $2,696 | $1,000 | -63% |
Vraylar | Bipolar 1 disorder; Major depressive disorder; Schizophrenia | $1,376 | $770 | -44% |
Tradjenta | Type 2 diabetes | $488 | $78 | -84% |
Janumet; Janumet XR | Type 2 diabetes | $526 | $80 | -85% |
Otezla; Otezla XR | Oral ulcers in Behçet’s Disease; Plaque psoriasis; Psoriatic arthritis | $4,722 | $1,650 | -65% |
The “2024 List Price” column shows the gross Wholesale Acquisition Cost (WAC) that Medicare Part D plans were charged in 2024 for a 30-day supply, before any rebates or discounts.
The “2027 Medicare Price” column is the Maximum Fair Price (MFP) manufacturers must offer Medicare starting January 1, 2027, for a 30-day supply.
Sources: CMS, November 2025 (pdf); Medicare prescription drug affordability fact sheet; Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability, Year 2027 (pdf)
List prices reflect typical Part D gross costs before rebates.
Related content
- 16 Strategies to Save Money on Prescription Drugs
- Here Are the 10 Medicare Negotiated Drug Prices
- Medicare to Cover Obesity Drugs Under Trump Deal for as Little as $50. What You Need to Know
- Seven Medicare Changes Coming in 2026
- Brace for Higher Health Costs in 2026: A Look at Projected Medicare Premiums
-
Countries That Will Pay You to Move: Cash Grants, Incentives and What to KnowExplore real relocation incentives — from cash grants and tax breaks to startup funding — that make moving abroad or to smaller towns more affordable and rewarding.
-
Mortgage Protection Insurance: What It Covers and When It Makes SenseHow mortgage protection insurance works, what it costs, and when it’s actually useful in a financial plan.
-
How to Use Your Health Savings Account in RetirementStrategic saving and investing of HSA funds during your working years can unlock the full potential of these accounts to cover healthcare costs and more in retirement.
-
How to Use Your Health Savings Account in Retirement
Strategic saving and investing of HSA funds during your working years can unlock the full potential of these accounts to cover healthcare costs and more in retirement.
-
I'm a Real Estate Expert: 2026 Marks a Seismic Shift in Tax Rules, and Investors Could Reap Millions in RewardsThree major tax strategies will align in 2026, creating unique opportunities for real estate investors to significantly grow their wealth. Here's how it works.
-
When Can Tax Planning Be an Act of Love? This Family Found OutHow can you give stock worth millions to a loved one without giving them a huge capital gains tax bill? This family's financial adviser provided the answer.
-
Who Said That? Match the US President to the QuotationWho better to give advice on aging, retirement and finances than a U.S. president? Our short quiz will determine whether you're a history buff or buffoon.
-
Gray Divorce After 50: Managing the Shift to Your Solo 'Second Act'Gray divorce presents complex challenges for families, yet it can also catalyze self-discovery and a vibrant new chapter.
-
The Paradox Between Money and Wealth: How Do You Find the Balance?Wealth reflects a life organized around relationships, health, contribution and time — qualities that compound differently than money in a mutual fund.
-
General Partner Stakes: Why Investors Are Buying Into the Business of Private EquityGP stakes in asset management firms offer exposure to private markets and are no longer just for the wealthy. Find out why it looks like a good year to invest.
-
Will Soaring Health Care Premiums Tank Your Early Retirement?If you're under 65 and want to retire soon, your plan may be derailed by skyrocketing ACA marketplace premiums. Here's what you can do.
